| Date Filed | Type | Description |
| 10/10/2023 |
8-K
| Quarterly results |
| 08/15/2023 |
4
| Eaton Bruce (EVP, CBO AND CTO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 702 shares
@ $8.5935, valued at
$6k
|
|
| 08/10/2023 |
4
| Eaton Bruce (EVP, CBO AND CTO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 141 shares
@ $8.39, valued at
$1.2k
|
|
| 08/04/2023 |
SC 13G
| Deep Track Capital, LP reports a 5.5% stake in EDITAS MEDICINE, INC. |
| 08/02/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/02/2023 |
8-K
| Quarterly results |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
| 06/07/2023 |
4
| O'Neill Gilmore Neil (CEO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 6,486 shares
@ $9.5032, valued at
$61.6k
|
|
| 06/07/2023 |
4
| Eaton Bruce (EVP, CBO AND CTO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 105 shares
@ $9.503, valued at
$997.8 |
|
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/18/2023 |
4
| Lucera Erick (EVP, CFO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 77,900 shares
@ $0
Granted 155,800 options to buy
@ $9.61, valued at
$1.5M
|
|
| 05/18/2023 |
3
| Lucera Erick (EVP, CFO) has filed a Form 3 on Editas Medicine, Inc. |
| 05/17/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/15/2023 |
4
| ROBERTSON MICHELLE (EVP, CFO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 949 shares
@ $9.872, valued at
$9.4k
|
|
| 05/15/2023 |
4
| Eaton Bruce (EVP, CBO AND CTO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 668 shares
@ $9.872, valued at
$6.6k
|
|
| 05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/11/2023 |
4
| Eaton Bruce (EVP, CBO AND CTO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 135 shares
@ $9.51, valued at
$1.3k
|
|
| 05/05/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/05/2023 |
8-K
| Quarterly results |
| 04/18/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/18/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/18/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/13/2023 |
8-K
| Quarterly results |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/14/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/06/2023 |
4
| ROBERTSON MICHELLE (EVP, CFO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 31,500 shares
@ $0
Sold 184 shares
@ $8.89, valued at
$1.6k
Granted 94,500 options to buy
@ $8.72, valued at
$824k
|
|
| 03/06/2023 |
4
| Mei Baisong (SVP, CHIEF MEDICAL OFFICER) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 18,000 shares
@ $0
Granted 54,000 options to buy
@ $8.72, valued at
$470.9k
|
|
| 03/06/2023 |
4
| O'Neill Gilmore Neil (CEO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 50,000 shares
@ $0
Granted 150,000 options to buy
@ $8.72, valued at
$1.3M
|
|
| 03/06/2023 |
4
| Eaton Bruce (EVP, CBO AND CTO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 16,700 shares
@ $0
Sold 101 shares
@ $8.89, valued at
$897.9
Granted 50,000 options to buy
@ $8.72, valued at
$436k
|
|
| 02/22/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
|